The Nonclinical Safety Assessment of a Novel Anti-CEACAM5 Antibody Exatecan Conjugate Predicts a Low Risk for Interstitial Lung Disease (ILD) in Patients—The Putative Mechanism Behind ILD
1. 系统已在2025-05-02 10:25:37对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1177/10915818241306039
文献链接: https://journals.sagepub.com/doi/10.1177/10915818241306039
其他信息:
出版社: SAGE Publications
作者: Willem N. Sloot; Elisa Bertotti; Manuela Onidi; Andrea Paoletti; Ilse De Salve; Patrizia Tavano; Enrico Vigna; Gundi Mueller
全文下载地址: https://journals.sagepub.com/doi/pdf/10.1177/10915818241306039